- Home
- OKYO vs FONR Comparison
OKYO vs FONR Comparison
Compare OKYO & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKYO
- FONR
- Stock Information
- Founded
- OKYO 2007
- FONR 1978
- Country
- OKYO United Kingdom
- FONR United States
- Employees
- OKYO N/A
- FONR N/A
- Industry
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- OKYO Health Care
- FONR Health Care
- Exchange
- OKYO Nasdaq
- FONR Nasdaq
- Market Cap
- OKYO 85.0M
- FONR 100.6M
- IPO Year
- OKYO 2022
- FONR 1987
- Fundamental
- Price
- OKYO $2.11
- FONR $15.32
- Analyst Decision
- OKYO Strong Buy
- FONR
- Analyst Count
- OKYO 1
- FONR 0
- Target Price
- OKYO $7.00
- FONR N/A
- AVG Volume (30 Days)
- OKYO 56.1K
- FONR 9.9K
- Earning Date
- OKYO 07-18-2025
- FONR 09-12-2025
- Dividend Yield
- OKYO N/A
- FONR N/A
- EPS Growth
- OKYO N/A
- FONR N/A
- EPS
- OKYO N/A
- FONR 1.21
- Revenue
- OKYO N/A
- FONR $104,351,318.00
- Revenue This Year
- OKYO N/A
- FONR N/A
- Revenue Next Year
- OKYO N/A
- FONR N/A
- P/E Ratio
- OKYO N/A
- FONR $12.77
- Revenue Growth
- OKYO N/A
- FONR 1.43
- 52 Week Low
- OKYO $0.90
- FONR $12.00
- 52 Week High
- OKYO $3.35
- FONR $17.98
- Technical
- Relative Strength Index (RSI)
- OKYO 35.10
- FONR 43.08
- Support Level
- OKYO $2.06
- FONR $15.19
- Resistance Level
- OKYO $2.17
- FONR $15.79
- Average True Range (ATR)
- OKYO 0.14
- FONR 0.26
- MACD
- OKYO -0.00
- FONR -0.03
- Stochastic Oscillator
- OKYO 12.50
- FONR 16.05
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.